(7S,7aS,14S,14aR)-1,7,7a,8,9,10,11,13,14,14a-Decahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1′,2′-e][1,5]diazocin-2-one

(7S,7aS,14S,14aR)-1,7,7a,8,9,10,11,13,14,14a-Decahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1′,2′-e][1,5]diazocin-2-one Basic Attributes

Characteristics

Latest News on (7S,7aS,14S,14aR)-1,7,7a,8,9,10,11,13,14,14a-Decahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1′,2′-e][1,5]diazocin-2-one

• Forecast and analysis of market size and entry barriers of China's pharmaceutical intermediates industry
• Pharmaceutical intermediates: the future development of adenine

Learn More Other Chemicals

• 2-Methoxy-5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

  1083168-84-6

• 2-iodo-2,3-dihydroinden-1-one

  113021-30-0

• 2,2-DIMETHYL-N-[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PYRIDIN-2-YL]-PROPIONAMIDE

  532391-30-3

• 6-Methylbenzoxazole Formula

  10531-80-3

• Methyl N-formylanthranilate Formula

  41270-80-8

• 1-(4-amino-3,5-dichlorophenyl)-2-(dimethylamino)ethanol Formula

  4812-69-5

• 2,5-Dihydroxy-N-(2-hydroxyethyl)benzamide Structure

  61969-53-7

• Benzenemethanol, α-(aminomethyl)-4-(1-methylethyl)- Structure

  91339-24-1

• What is 5-Hydroxy-2-iodobenzaldehyde

  50765-11-2

• What is 4-(Pyridin-2-yl)Butanoic Acid

  102879-51-6